Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Mol Sci
2019 Mar 21;206:. doi: 10.3390/ijms20061438.
Show Gene links
Show Anatomy links
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold.
Guerrini G
,
Vergelli C
,
Cantini N
,
Giovannoni MP
,
Daniele S
,
Mascia MP
,
Martini C
,
Crocetti L
.
???displayArticle.abstract???
We previously published a series of 8-methoxypirazolo[1,5-a]quinazolines (PQs) and their 4,5-dihydro derivatives (4,5(H)PQ) bearing the (hetero)arylalkylester group at position 3 as ligands at the γ-aminobutyric type A (GABAA) subtype receptor. Continuing the study in this field, we report here the design and synthesis of 3-(hetero)arylpyrazolo[1,5-a]quinazoline and 3-(hetero)aroylpyrazolo[1,5-a]quinazoline 8-methoxy substituted as interesting analogs of the above (hetero)arylalkylester, in which the shortening or the removal of the linker between the 3-(hetero)aryl ring and the PQ was performed. Only compounds that are able to inhibit radioligand binding by more than 80% at 10 μM have been selected for electrophysiological studies on recombinant α1β2γ2L GABAA receptors. Some compounds show a promising profile. For example, compounds 6a and 6b are able to modulate the GABAAR in an opposite manner, since 6b enhances and 6a reduces the variation of the chlorine current, suggesting that they act as a partial agonist and an inverse partial agonist, respectively. The most potent derivative was 3-(4-methoxyphenylcarbonyl)-8-methoxy-4,5-dihydropyrazolo[1,5-a] quinazoline 11d, which reaches a maximal activity at 1 μM (+54%), and it enhances the chlorine current at ≥0.01 μM. Finally, compound 6g, acting as a null modulator at α1β2γ2L, shows the ability to antagonize the full agonist diazepam and the potentiation of CGS 9895 on the new α+/β- 'non-traditional' benzodiazepine site.
Figure 1. Panel (A): γ-aminobutyric type A (GABAA) receptor subtype ligands with chemical structures strictly related to the new pyrazoloquinazoline (PQ). Panel (B): general structure of new synthesized PQ compounds. Blue circle 3-aroylpyrazolopyrimidine moiety; Red circle 3-arylpyrazolopyrimidina moiety.
Scheme 1. Synthesis of pyrazolo[1,5-a]quinazolin-4(5H)-ones and pyrazolo[1,5-a]quinazolines bearing an aryl/heteroaryl ring or aroyl/heteroaroyl group at position 3. Reagents and conditions: (i) AcOH or dimethylformamide (DMF)/AcONa; (ii) anhydrous THF and LiAlH4/THF then air; (iii) POCl3/PCl5,N,N-diisopropylethylamine (DIPEA); (iv) EtOH, HCOONH4, Pd/C 10%.
Scheme 2. Synthesis of 3-(hetero)arylpyrazolo[1,5-a]quinazoline. Reagents and conditions: (i) anhydrous THF and LiAlH4/THF; then, toluene, 10% Pd/C. (ii) Br2 or NIS, CH2Cl2; (iii) Suzuki conditions, arylboronic acids, ethanol abs., (PPh3)4Pd tetrakis(triphenylphosphine)palladium (0), sodium carbonate 2 M; (iv) THF/MeONa.
Scheme 3. Synthesis of 3-(hetero)aroylpyrazolo[1,5-a]quinazoline derivatives. Reagents and conditions: (i) For compound 6d Eaton’s reagent and anisole; for 6e–g: SOCl2 or Cl3CCN/PPh3, then SnCl4 and suitable ArH/HetH; (ii) SOCl2, 2-MeO-PhB(OH)2, toluene, Na2CO3 sol. 2 M; (iii) DMF, K2CO3, MeI.
Scheme 4. Synthesis of 3-(hetero)aroyl-4,5-dihydropyrazolo[1,5-a]quinazolines. Reagents and conditions: (i) AcOH/NaBH3CN.
Figure 2. Concentration-response curves of compounds (A) 5d–f, (B) 6a–d, 6f,g, and (C) 11a,b,d on GABA-induced Cl− currents in Xenopus oocytes expressing recombinant α1β2γ2L GABAA receptors. Data are expressed as the percentage modulation of the response induced by GABA at EC5–10 values, and are the mean ± S.E.M of values obtained from two to nine oocytes. ** p < 0.01; * p < 0.05 Kruskal–Wallis test followed by the Dunn post-hoc test.
Figure 3. Compound 6g antagonized the potentiation of GABA-induced Cl− currents by diazepam in Xenopus oocytes expressing recombinant α1β2γ2L GABAA receptors. Data are expressed as the percentage potentiation of the response induced by GABA at EC5–10 values, and are the mean ± SEM of values obtained from four oocytes. p < 0.05 Mann–Whitney test.
Figure 4. Compound 6g reduced the potentiation of GABA-induced Cl− currents by CGS 9895 (2-p-methoxyphenylpyrazolo[4,3-c]quinolin-3-(5H)-one) in Xenopus oocytes expressing recombinant α1β2 GABAA receptors. Data are expressed as the percentage potentiation of the response induced by GABA at EC5–10 values, and are the mean ± SEM of values obtained from three to six oocytes.
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels.
2017, Pubmed
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels.
2017,
Pubmed
Avoli,
Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro.
2002,
Pubmed
Baur,
Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
2008,
Pubmed
,
Xenbase
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Chua,
GABAA Receptors and the Diversity in their Structure and Pharmacology.
2017,
Pubmed
Costanzo,
Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides.
1999,
Pubmed
Feng,
Comparison of αβδ and αβγ GABAA receptors: Allosteric modulation and identification of subunit arrangement by site-selective general anesthetics.
2018,
Pubmed
Guerrini,
Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
2008,
Pubmed
Guerrini,
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands.
2017,
Pubmed
Guerrini,
Identification of a New Pyrazolo[1,5-a]quinazoline Ligand Highly Affine to γ-Aminobutyric Type A (GABAA) Receptor Subtype with Anxiolytic-Like and Antihyperalgesic Activity.
2017,
Pubmed
Guerrini,
A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABAA) receptor subtype ligand: synthesis and pharmacological evaluation.
2018,
Pubmed
Knutson,
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.
2018,
Pubmed
Krall,
GABAA receptor partial agonists and antagonists: structure, binding mode, and pharmacology.
2015,
Pubmed
LOWRY,
Protein measurement with the Folin phenol reagent.
1951,
Pubmed
Lemon,
Indiplon in the management of insomnia.
2009,
Pubmed
Maldifassi,
Molecular mode of action of CGS 9895 at α1 β2 γ2 GABAA receptors.
2016,
Pubmed
,
Xenbase
Martini,
Isolation of putative benzodiazepine receptors from rat brain membranes by affinity chromatography.
1982,
Pubmed
Mascia,
Differential modulation of GABA(A) receptor function by aryl pyrazoles.
2014,
Pubmed
,
Xenbase
Miller,
Crystal structure of a human GABAA receptor.
2014,
Pubmed
Primofiore,
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
2001,
Pubmed
Ramerstorfer,
The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
2011,
Pubmed
,
Xenbase
Sieghart,
A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.
2012,
Pubmed
Sieghart,
International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans.
2018,
Pubmed
Simeone,
Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes.
2017,
Pubmed
,
Xenbase
Skolnick,
Anxioselective anxiolytics: on a quest for the Holy Grail.
2012,
Pubmed
Varagic,
Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
2013,
Pubmed
,
Xenbase
Varagic,
Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
2013,
Pubmed
,
Xenbase
Walters,
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms.
2000,
Pubmed
,
Xenbase
Wongsamitkul,
α subunits in GABAA receptors are dispensable for GABA and diazepam action.
2017,
Pubmed
,
Xenbase
Zhu,
Structure of a human synaptic GABAA receptor.
2018,
Pubmed
